This Week at FDA: Pfizer’s tornado fallout, penicillin shortage, and FY2024 user fees

This Week at FDA

This Week at FDAFerdous Al-Faruque • Joanne S. Eglovitch

Biologics/ biosimilars/ vaccinesMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy